BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 11237521)

  • 1. PTEN: life as a tumor suppressor.
    Simpson L; Parsons R
    Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
    Steelman LS; Bertrand FE; McCubrey JA
    Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
    Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    Maehama T; Dixon JE
    J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PTEN: a tumor suppressor with original properties].
    Roux P
    Bull Cancer; 1999 Jun; 86(6):522-5. PubMed ID: 10417424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.
    Besson A; Robbins SM; Yong VW
    Eur J Biochem; 1999 Aug; 263(3):605-11. PubMed ID: 10469123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN expression causes feedback upregulation of insulin receptor substrate 2.
    Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
    Mol Cell Biol; 2001 Jun; 21(12):3947-58. PubMed ID: 11359902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
    Longy M
    Bull Cancer; 2001 Dec; 88(12):1153-8. PubMed ID: 11792608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cowden disease].
    Sawada T; Hamano N; Suzuki A; Okada T; Mabuchi H
    Nihon Rinsho; 2000 Jul; 58(7):1479-83. PubMed ID: 10921327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
    Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
    Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PTEN--a new tumor inhibitory gene].
    Tian X; Wu H
    Zhonghua Bing Li Xue Za Zhi; 2000 Dec; 29(6):455-7. PubMed ID: 12790140
    [No Abstract]   [Full Text] [Related]  

  • 15. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
    Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB
    Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
    Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN and cancer.
    Parsons R; Simpson L
    Methods Mol Biol; 2003; 222():147-66. PubMed ID: 12710685
    [No Abstract]   [Full Text] [Related]  

  • 20. INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
    Kofuji S; Kimura H; Nakanishi H; Nanjo H; Takasuga S; Liu H; Eguchi S; Nakamura R; Itoh R; Ueno N; Asanuma K; Huang M; Koizumi A; Habuchi T; Yamazaki M; Suzuki A; Sasaki J; Sasaki T
    Cancer Discov; 2015 Jul; 5(7):730-9. PubMed ID: 25883023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.